[HTML][HTML] Molecular biology of osteosarcoma

AM Czarnecka, K Synoradzki, W Firlej, E Bartnik… - Cancers, 2020 - mdpi.com
Osteosarcoma (OS) is the most frequent primary bone cancer in children and adolescents
and the third most frequent in adults. Many inherited germline mutations are responsible for …

[HTML][HTML] Deciphering the signaling mechanisms of osteosarcoma tumorigenesis

BK Nirala, T Yamamichi, JT Yustein - International Journal of Molecular …, 2023 - mdpi.com
Osteosarcoma (OS) is the predominant primary bone tumor in the pediatric and adolescent
populations. It has high metastatic potential, with the lungs being the most common site of …

[HTML][HTML] Advances in targeted therapy for osteosarcoma

W Zhou, M Hao, X Du, K Chen, G Wang… - Discovery …, 2014 - discoverymedicine.com
Osteosarcoma is an aggressive cancer in skeletal system with unknown molecular
mechanisms of etiology and pathogenesis, therefore it remains a challenge for current …

[HTML][HTML] Osteosarcoma pathogenesis leads the way to new target treatments

I Fernandes, C Melo-Alvim, R Lopes-Brás… - International journal of …, 2021 - mdpi.com
Osteosarcoma (OS) is a rare condition with very poor prognosis in a metastatic setting. Basic
research has enabled a better understanding of OS pathogenesis and the discovery of new …

Biology of osteogenic sarcoma

LL Wang - The Cancer Journal, 2005 - journals.lww.com
Osteosarcoma is the most common primary malignant bone tumor in children and
adolescents. Despite significant clinical improvements over the past several decades …

Advances in targeted therapy for osteosarcoma based on molecular classification

Y Chen, R Liu, W Wang, C Wang, N Zhang… - Pharmacological …, 2021 - Elsevier
Osteosarcoma, a highly malignant tumor, is characterized by widespread and recurrent
chromosomal and genetic abnormalities. In recent years, a number of elaborated …

New molecular insights into osteosarcoma targeted therapy

J Yang, W Zhang - Current opinion in oncology, 2013 - journals.lww.com
Osteosarcoma is a relatively uncommon cancer, accounting for 5% of childhood cancers
and 8.9% of cancer-related deaths in children. The overall incidence is five cases per million …

Osteosarcoma: cells‐of‐origin, cancer stem cells, and targeted therapies

A Abarrategi, J Tornin, L Martinez-Cruzado… - Stem cells …, 2016 - Wiley Online Library
Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone.
Although standard chemotherapy has significantly improved long‐term survival over the past …

Targeted therapy for osteosarcoma: a review

S Li, H Zhang, J Liu, G Shang - Journal of cancer research and clinical …, 2023 - Springer
Background Osteosarcoma is a common primary malignant tumour of the bone that usually
occurs in children and adolescents. It is characterised by difficult treatment, recurrence and …

[HTML][HTML] Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy

B Sadikovic, P Thorner, S Chilton-MacNeill, JW Martin… - BMC cancer, 2010 - Springer
Background Human osteosarcoma is the most common pediatric bone tumor. There is
limited understanding of the molecular mechanisms underlying osteosarcoma oncogenesis …